Skip to main
PEN

Penumbra (PEN) Stock Forecast & Price Target

Penumbra (PEN) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 24%
Buy 18%
Hold 59%
Sell 0%
Strong Sell 0%

Bulls say

Penumbra is positioned for strong financial performance, with expectations for annual revenue growth of 21% or more, driven by innovative new products and improved profitability. The company is likely to enhance both gross and operating margins, leading to earnings per share (EPS) growth that outpaces revenue growth. Market dynamics, including a potential increase in thrombectomy referrals and favorable international expansion, further support a positive outlook for the firm.

Bears say

The analysis indicates that Penumbra's projected revenue growth is anticipated to fall to 14% or less, largely due to disappointing contributions from new products and underwhelming profitability improvements. Additionally, the company faces significant risks from heightened competition, potential delays in product clearances, and regulatory hurdles, which could adversely affect its market share and margins. Finally, contrasting valuation metrics highlight concerns; Penumbra trades at an elevated EV/sales multiple compared to its peers, further exacerbating the perceived risk associated with its stock.

Penumbra (PEN) has been analyzed by 17 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 18% recommend Buy, 59% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Penumbra and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Penumbra (PEN) Forecast

Analysts have given Penumbra (PEN) a Buy based on their latest research and market trends.

According to 17 analysts, Penumbra (PEN) has a Buy consensus rating as of Jan 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $353.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $353.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Penumbra (PEN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.